Volume 140, Issue 1, Pages (January 2011)

Slides:



Advertisements
Similar presentations
A Novel Cinnamide YLT26 Induces Breast Cancer Cells Apoptosis via ROS-Mitochondrial Apoptotic Pathway in Vitro and Inhibits.
Advertisements

Volume 133, Issue 1, Pages (July 2007)
The Combined Effects of Hematoporphyrin Monomethyl Ether-SDT and Doxorubicin on the Proliferation of QBC939 Cell Lines  Lei Liang, Sheng Xie, Lin Jiang,
Saikosaponin-D Enhances Radiosensitivity of Hepatoma Cells under Hypoxic Conditions by Inhibiting Hypoxia-Inducible Factor-1α Cell Physiol Biochem 2014;33:37-51.
Figure 1. Herbacetin binds to AKT1/2 and suppresses each respective kinase activity. The effect of herbacetin on (A) PI3K/AKT and (B) MAPK signaling pathway.
Induction of Apoptosis by Ethanol Extracts of Ganoderma lucidum in Human Gastric Carcinoma Cells  Kyung-Jun Jang, Min-Ho Han, Byung-Hoon Lee, Byung-Woo.
Figure 1. Herbacetin binds to AKT1/2 and suppresses each respective kinase activity. The effect of herbacetin on (A) PI3K/AKT and (B) MAPK signaling pathway.
Volume 18, Issue 12, Pages (December 2016)
Volume 145, Issue 2, Pages (August 2013)
Volume 143, Issue 3, Pages e2 (September 2012)
Vemurafenib Induces Senescence Features in Melanoma Cells
Microsomal Prostaglandin E Synthase-1 Inhibits PTEN and Promotes Experimental Cholangiocarcinogenesis and Tumor Progression  Dongdong Lu, Chang Han, Tong.
Volume 140, Issue 3, Pages (March 2011)
Volume 133, Issue 1, Pages (July 2007)
Volume 21, Issue 10, Pages (October 2013)
The Mitochondrial Protein hTID-1 Partners With the Caspase-Cleaved Adenomatous Polyposis Cell Tumor Suppressor to Facilitate Apoptosis  Jiang Qian, Erin.
Myung Jin Son, Kevin Woolard, Do-Hyun Nam, Jeongwu Lee, Howard A. Fine 
Volume 128, Issue 7, Pages (June 2005)
Volume 17, Issue 9, Pages (September 2009)
Volume 143, Issue 6, Pages (December 2012)
Bax and Bak have critical roles in ischemic acute kidney injury in global and proximal tubule–specific knockout mouse models  Qingqing Wei, Guie Dong,
Volume 135, Issue 1, Pages (July 2008)
Volume 25, Issue 3, Pages (March 2017)
The cell cycle and acute kidney injury
Volume 144, Issue 1, Pages e4 (January 2013)
Volume 138, Issue 7, Pages (June 2010)
Volume 139, Issue 1, Pages (July 2010)
Volume 136, Issue 2, Pages (February 2009)
Volume 131, Issue 5, Pages (November 2006)
Sp1 Is Required for Glucose-Induced Transcriptional Regulation of Mouse Vesicular Glutamate Transporter 2 Gene  Tao Li, Liqun Bai, Jing Li, Suzu Igarashi,
Volume 133, Issue 5, Pages (November 2007)
Volume 12, Issue 3, Pages (July 2015)
Volume 132, Issue 4, Pages (April 2007)
Volume 143, Issue 1, Pages e8 (July 2012)
Volume 131, Issue 5, Pages (November 2006)
TAT-mediated Delivery of LAD Restores Pyruvate Dehydrogenase Complex Activity in the Mitochondria of Patients with LAD Deficiency  Matan Rapoport, Ann.
Volume 138, Issue 5, Pages e2 (May 2010)
Volume 132, Issue 7, Pages (June 2007)
Volume 145, Issue 2, Pages (August 2013)
Volume 133, Issue 4, Pages (October 2007)
Volume 143, Issue 1, Pages e7 (July 2012)
Volume 18, Issue 2, Pages (February 2010)
MicroRNA-101 Exerts Tumor-Suppressive Functions in Non-small Cell Lung Cancer through Directly Targeting Enhancer of Zeste Homolog 2  Ji-guang Zhang,
Volume 143, Issue 1, Pages e8 (July 2012)
Volume 142, Issue 7, Pages e2 (June 2012)
Molecular Therapy - Nucleic Acids
Ryang Hwa Lee, Nara Yoon, John C. Reneau, Darwin J. Prockop 
Volume 134, Issue 4, Pages (April 2008)
Volume 21, Issue 10, Pages (October 2013)
1,25-dihydroxyvitamin D3 inhibits renal interstitial myofibroblast activation by inducing hepatocyte growth factor expression  Yingjian Li, Bradley C.
miR-124 Inhibits Lung Tumorigenesis Induced by K-ras Mutation and NNK
Microsomal Prostaglandin E Synthase-1 Inhibits PTEN and Promotes Experimental Cholangiocarcinogenesis and Tumor Progression  Dongdong Lu, Chang Han, Tong.
Molecular Therapy - Nucleic Acids
Volume 124, Issue 7, Pages (June 2003)
Molecular Therapy - Nucleic Acids
Volume 19, Issue 8, Pages (August 2011)
The pathological role of Bax in cisplatin nephrotoxicity
Arsenic Induces Tumor Necrosis Factor α Release and Tumor Necrosis Factor Receptor 1 Signaling in T Helper Cell Apoptosis  Hsin-Su Yu, Gwo-Shing Chen 
Suppression of IGF1R in Melanoma Cells by an Adenovirus-Mediated One-Step Knockdown System  Haoran Xin, Mingxing Lei, Zhihui Zhang, Jie Li, Hao Zhang,
Thomas S. Griffith, Elizabeth L. Broghammer  Molecular Therapy 
Green Tea Polyphenol Epigallocatechin-3-Gallate Suppresses Collagen Production and Proliferation in Keloid Fibroblasts via Inhibition of the STAT3-Signaling.
Shrimp miR-34 from Shrimp Stress Response to Virus Infection Suppresses Tumorigenesis of Breast Cancer  Yalei Cui, Xiaoyuan Yang, Xiaobo Zhang  Molecular.
Volume 20, Issue 1, Pages (January 2012)
Volume 25, Issue 7, Pages (July 2017)
LncRNA ZEB1-AS1 Was Suppressed by p53 for Renal Fibrosis in Diabetic Nephropathy  Juan Wang, Jian Pang, Huiling Li, Jie Long, Fang Fang, Junxiang Chen,
Fan Yang, Huafeng Zhang, Yide Mei, Mian Wu  Molecular Cell 
Volume 26, Issue 1, Pages (January 2018)
Endostatin: An Endogenous Inhibitor of Angiogenesis and Tumor Growth
Xiao Zhen Zhou, Kun Ping Lu  Cell 
Molecular Therapy - Nucleic Acids
Presentation transcript:

Volume 140, Issue 1, Pages 332-343 (January 2011) HIV-Tat–Mediated Delivery of an LPTS Functional Fragment Inhibits Telomerase Activity and Tumorigenicity of Hepatoma Cells  Guangming Chen, Liang Da, Hongfei Wang, Ying Xu, Guoyuan Chen, Chengfu Sun, Leiming Wang, Jing Zhao, Fang Zhang, Jian Feng, Yifei Wang, Pierre Tiollais, Tsaiping Li, Mujun Zhao  Gastroenterology  Volume 140, Issue 1, Pages 332-343 (January 2011) DOI: 10.1053/j.gastro.2010.08.046 Copyright © 2011 AGA Institute Terms and Conditions

Figure 1 Expression and telomerase inhibitory function of LPTS proteins. (A) Expression of LPTS proteins in human HCC tissues (C) and adjacent nontumor tissues (N) was analyzed by Western blotting. β-tubulin was loaded as an internal control. (B) Identification of the regions of LPTS proteins effectively inhibiting telomerase activity. (C) Twelve percent polyacrylamide gel showed telomerase activities inhibited by GST-fused LPTS and LPTS deletions. Various concentrations of GST fusion proteins were used as indicated. GST without LPTS and RNase A acted as negative and positive controls, respectively. Gastroenterology 2011 140, 332-343DOI: (10.1053/j.gastro.2010.08.046) Copyright © 2011 AGA Institute Terms and Conditions

Figure 2 The TAT-LPTS-LC protein is delivered into cells and inhibits telomerase activity in vitro. (A) Schematic representation of TAT-LPTS-LC protein. (B) Ten percent sodium dodecyl sulfate–polyacrylamide gel electrophoresis analysis of recombinant TAT-LPTS-LC fusion protein. Lane 1, protein molecular weight marker; lane 2, cell lysate of E coli BL21 before or after (lane 3) IPTG induction; lane 4, total proteins in the supernatant; lane 5, affinity chromatography purified TAT-LPTS-LC protein. (C) Various concentrations of TAT-LPTS-LC as indicated were used to measure the inhibition of telomerase activity. (D) Western blotting analysis of transduction of TAT-LPTS-LC proteins into BEL-7404 and Saos-2 cells. The cells were incubated with proteins for the indicated times. (E) Immunofluorescence of BEL-7404 and Saos-2 cells transduced with TAT-LPTS-LC proteins. Gastroenterology 2011 140, 332-343DOI: (10.1053/j.gastro.2010.08.046) Copyright © 2011 AGA Institute Terms and Conditions

Figure 3 TAT-LPTS-LC inhibits telomerase-positive cell proliferation. (A) The inhibition of cell growth was evaluated by colorimetric tetrazolium salt (MTT) assay. (B) Percentages of dying cells were counted and presented. (C) Cell death was measured by the flow cytometry. The cell populations in sub-G1 were referred to as necrotic cells. All the data are presented as mean ± SD from at least 3 independent experiments. Gastroenterology 2011 140, 332-343DOI: (10.1053/j.gastro.2010.08.046) Copyright © 2011 AGA Institute Terms and Conditions

Figure 4 TAT-LPTS-LC induces cell crisis and shortens telomere length. (A) Photographs of the cells treated with TAT-LPTS-LC or PBS. (B) Photographs of the treated cell nuclei stained by 4',6-diamidino-2-phenylindole. The white arrows indicate the crisis cells and the red arrows show apoptotic cells. (C) Southern blotting analysis of telomere length of BEL-7404 and L02 cells after treatment. The a-32P-labeled TTAGGGA repeats was used as a probe. Gastroenterology 2011 140, 332-343DOI: (10.1053/j.gastro.2010.08.046) Copyright © 2011 AGA Institute Terms and Conditions

Figure 5 TAT-LPTS-LC decreases tumorigenicity of BEL-7404 cells in nude mice. (A) Calculation of tumor appearance at injected sites weekly. Seven mice were used per group. (B) Representative photographs of one mouse in each group. (C) Tumors were harvested and weighed 7 weeks after injection. Gastroenterology 2011 140, 332-343DOI: (10.1053/j.gastro.2010.08.046) Copyright © 2011 AGA Institute Terms and Conditions

Figure 6 TAT-LPTS-LC suppresses the xenograft growth of BEL-7404 cells in nude mice. (A) The TAT-GFP protein was delivered into tumors and organs analyzed by GFP imaging. (B) Western blotting analysis of the TAT-LPTS-LC proteins reached to the tumors and organs. (C) The tumor volumes were calculated weekly. Data are presented as means ± standard deviation (n = 5). (D) At 7 weeks after xenografting, the tumors were removed and photographed. The average tumor weights were counted. Statistical significance was set at a P value of less than .05. Gastroenterology 2011 140, 332-343DOI: (10.1053/j.gastro.2010.08.046) Copyright © 2011 AGA Institute Terms and Conditions

Figure 7 Evaluation of toxicity of TAT-LPTS-LC. (A) The main organs collected from normal and xenografting mice after treatment. (B) The serum biochemistry parameters and complete blood counts were analyzed. BUN, blood urea nitrogen; CRE, creatinine; HGB, hemoglobin; PLT, platelet count; RBC, red blood cell; WBC, white blood cell. The values represent averages for 5 mice. (C) The median lethal dose (LD50) of TAT-LPTS-LC on Kunming mice. Gastroenterology 2011 140, 332-343DOI: (10.1053/j.gastro.2010.08.046) Copyright © 2011 AGA Institute Terms and Conditions